Skip to main content

Table 3 Association between centrosome amplification level and prognostic factors of breast carcinoma

From: Analysis of the cellular centrosome in fine-needle aspirations of the breast

Variable Cases (n) Centrosome amplification, mean ± standard deviation (%)
   Structural P value Numerical P value
Tumor size
   ≤2 cm 40 4.01 ± 3.52 0.97 5.09 ± 3.05 0.50
   >2 cm 32 3.98 ± 2.98   4.65 ± 2.25  
Nodal status
   Negative 37 4.17 ± 3.59 0.60 5.24 ± 2.99 0.26
   Positive 37 3.77 ± 2.88   4.53 ± 2.31  
Histological grade
   Grade 1 12 4.03 ± 3.83   5.10 ± 1.90  
   Grade 2 50 3.67 ± 3.07 0.69 5.08 ± 2.90 0.98
   Grade 3 10 5.26 ± 3.60 0.11 3.65 ± 2.35 0.13
ER status
   Positive 52 3.26 ± 2.82 0.003 5.31 ± 2.72 0.03
   Negative 23 5.60 ± 3.51   3.84 ± 2.30  
PR status
   Positive 63 3.6 ± 2.8 0.056 5.17 ± 2.71 0.02
   Negative 12 6.2 ± 4.3   3.22 ± 1.74  
HER2/neu overexpression
   Positive 14 6.09 ± 3.97 0.005 4.01 ± 2.08 0.19
   Negative 61 3.49 ± 2.84   5.05 ± 2.76  
DNA ploidy
   Diploidy 7 5.21 ± 3.81   4.07 ± 2.13  
   Aneuploidy 31 4.40 ± 3.59 0.59 5.10 ± 2.86 0.36
   Multiploidy 6 3.01 ± 3.62 0.40 5.37 ± 2.07 0.83